222 research outputs found
Correction: Teeuwssen and fodde; colon cancer heterogeneity and phenotypic plasticity in metastasis formation (Cancers (2019) 11, 9, 1368)
The authors would like to make a correction to their published paper [1]. The authors would like to change one incorrect sentence in reference [1]. On page 9, in paragraph 2, the sentence "In colon cancer, CAFs release exosomes containing miR-92a-3p and promote invasion and chemotherapy resistance. miR-92a-3p directly binds to FBXW7 and MOAP1 thereby activating Wnt-induced EMT and mitochondrial apoptosis [89]'should be changed to "In colon cancer, CAFs release exosomes containing miR-92a-3p and promote invasion and chemotherapy resistance. miR-92a-3p directly binds to FBXW7 and MOAP1 thereby activating Wnt-induced EMT and inhibiting mitochondrial apoptosis [89]." The change does not affect the scientific results. The rest of the manuscript does not to be changed. The authors would like to apologize for any inconvenience caused. The manuscript will be updated, and the original will remain available on the article webpage
Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
Ovarian cancers represent the deadliest among gynecologic malignancies and are
characterized by a hierarchical structure with cancer stem cells (CSCs) endowed with self-renewal
and the capacity to differentiate. The Wnt/β-catenin signaling pathway, known to regulate stemness
in a broad spectrum of stem cell niches including the ovary, is thought to play an important role
in ovarian cancer. Importantly, Wnt activity was shown to correlate with grade, epithelial to
mesenchymal transition, chemotherapy resistance, and poor prognosis in ovarian cancer. This review
will discuss the current knowledge of the role of Wnt signaling in ovarian cancer stemness, epithelial to
mesenchymal transition (EMT), and therapy resistance. In addition, the alleged role of exosomes
in the paracrine activation of Wnt signaling and pre-metastatic niche formation will be reviewed.
Finally, novel potential treatment options based on Wnt inhibition will be highlighted
Wnt/Î-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
A delicate balance between estrogen and progestagen signaling underlies proper functioning of the female reproductive tract and, in particular, the monthly re- and degenerative phases characteristic of the menstrual cycle. Here, we propose that the canonical Wnt/β-catenin signaling pathway may underlie this finely tuned hormonal equilibrium in endometrial homeostasis and, upon its constitutive activation, lead to neoplastic transformation of the endometrium. During the menstrual cycle, estradiol will enhance Wnt/β-catenin signaling in the proliferative phase, while progesterone inhibits Wnt/β-catenin signaling, thus restraining estrogens' proliferative actions, during the secretory phase. In case of enhanced or unopposed estrogen signaling, constitutive activation of Wnt/β-catenin signaling will trigger endometrial hyperplasia, which may develop further into endometrial cancer
Stem Cells and Metastatic Cancer: Fatal Attraction?
Fodde discusses a new study in PLoS ONE, by Aboody and colleagues, who report on the successful eradication of whole-body disseminated metastases in a mouse model of neuroblastoma
Cell heterogeneity and phenotypic plasticity in metastasis formation: The case of colon cancer
The adenoma-to-carcinoma progression in colon cancer is driven by a sequential accumulation of genetic alterations at specific tumor suppressors and oncogenes. In contrast, the multistage route from the primary site to metastasis formation is underlined by phenotypic plasticity, i.e., the capacity of disseminated tumor cells to undergo transiently and reversible transformations in order to adapt to the ever-changing environmental contexts. Notwithstanding the considerable body of evidence in support of the role played by epithelial-to-mesenchymal transition (EMT)/mesenchymal-to-epithelial transition (MET) in metastasis, its rate-limiting function, the detailed underlying cellular and molecular mechanisms, and the extension of the necessary morphologic and epigenetic changes are still a matter of debate. Rather than leading to a complete epithelial or mesenchymal state, the EMT/MET-program generates migrating cancer cells displaying intermediate phenotypes featuring both epithelial and mesenchymal characteristics. In this review, we will address the role of colon cancer heterogeneity and phenotypic plasticity in metastasis formation and the contribution of EMT to these processes. The alleged role of hybrid epithelial/mesenchymal (E/M) in collective and/or single-cell migration during local dissemination at the primary site and more systemic spreading will also be highlighted
Generation and characterization of an inducible transgenic model for studying mouse esophageal biology
Background: To facilitate the in vivo study of esophageal (stem) cell biology in homeostasis and cancer, novel mouse models are necessary to elicit expression of candidate genes in a tissue-specific and inducible fashion. To this aim, we developed and studied a mouse model to allow labeling of esophageal cells with the histone 2B-GFP (H2B-GFP) fusion protein. Results: First, we generated a transgenic mouse model expressing the reverse tetracycline transactivator rtTA2-M2 under control of the promoter (ED-L2) of the Epstein-Barr virus (EBV) gene encoding the latent membrane protein-1 (LMP-1). The newly generated ED-L2-rtTA2-M2 (ED-L2-rtTA) mice were then bred with the previously developed tetO-HIST1H2BJ/GFP (tetO-H2B-GFP) model to assess inducibility and tissue-specificity. Expression of the H2B-GFP fusion protein was observed upon doxycycline induction but was restricted to the terminally differentiated cells above the basal cell layer. To achieve expression in the basal compartment of the esophagus, we ubsequently employed a different transgenic model expressing the reverse transactivator rtTA2S-M2 under the control of the ubiquitous, methylation-free CpG island of the human hnRNPA2B1-CBX3 gene (hnRNP-rtTA). Upon doxycycline administration to the compound hnRNP-rtTA/tetO-H2B-GFP mice, near-complete labeling of all esophageal cells was achieved. Pulse-chase experiments confirmed that complete turnover of the esophageal epithelium in the adult mouse is achieved within 710 days. Conclusions: We show that the esophagus-specific promoter ED-L2 is expressed only in the differentiated cells above the basal layer. oreover, we confirmed that esophageal turn-over in the adult mouse does not exceed 710 days
Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer
Phenotypic plasticity allows carcinoma cells to transiently acquire the quasi-mesenchymal features necessary to detach from the primary mass and proceed along the invasion-metastasis cascade. A broad spectrum of epigenetic mechanisms is likely to cause the epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial (MET) transitions necessary to allow local dissemination and distant metastasis. Here, we report on the role played by alternative splicing (AS) in eliciting phenotypic plasticity in epithelial malignancies with focus on colon cancer. By taking advantage of the coexistence of subpopulations of fully epithelial (EpCAM(hi)) and quasi-mesenchymal and highly metastatic (EpCAM(lo)) cells in conventional human cancer cell lines, we here show that the differential expression of ESRP1 and other RNA-binding proteins (RBPs) downstream of the EMT master regulator ZEB1 alters the AS pattern of a broad spectrum of targets including CD44 and NUMB, thus resulting in the generation of specific isoforms functionally associated with increased invasion and metastasis. Additional functional and clinical validation studies indicate that both the newly identified RBPs and the CD44s and NUMB2/4 splicing isoforms promote local invasion and distant metastasis and are associated with poor survival in colon cancer. The systematic elucidation of the spectrum of EMT-related RBPs and AS targets in epithelial cancers, apart from the insights in the mechanisms underlying phenotypic plasticity, will lead to the identification of novel and tumor-specific therapeutic targets
Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH.
Comparative genomic hybridization by means of BAC microarrays (array CGH)
allows high-resolution profiling of copy-number aberrations in tumor DNA.
However, specific genetic lesions associated with small but clinically
relevant tumor areas may pass undetected due to intra-tumor heterogeneity
and/or the presence of contaminating normal cells. Here, we show that the
combination of laser capture microdissection, phi29 DNA
polymerase-mediated isothermal genomic DNA amplification, and array CGH
allows genomic profiling of very limited numbers of cells. Moreover, by
means of simple statistical models, we were able to bypass the exclusion
of amplification distortions and variability prone areas, and to detect
tumor-specific chromosomal gains and losses. We applied this new combined
experimental and analytical approach to the genomic profiling of
colorectal adenomatous polyps and demonstrated our ability to accurately
detect single copy gains and losses affecting either whole chromosomes or
small genomic regions from as little as 2 ng of DNA or 1000 microdissected
cells
Smad4 haploinsufficiency: a matter of dosage
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
- âŚ